You are here

Merck wins record US$2.5b patent verdict against Gilead

New York

GILEAD Sciences Inc - the biopharmaceutical giant with a market capitalisation of US$100 billion, which Singapore's Temasek Holdings owns 1.05 per cent of, was told by a US federal jury to pay US$2.54 billion to Merck & Co for using a patented invention as the basis for its

sentifi.com

Market voices on:

Powered by GET.comGetCom